Status:
UNKNOWN
A Comparative Study of Sibling Oocytes: ICSI vs. the IMSI Sperm Selection Method
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Infertility
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
The aim of this research is to compare sibling oocytes using two sperm selection methods for choosing the best quality spermatozoa before they are injected into oocytes and the influence of each of th...
Eligibility Criteria
Inclusion
- Males aged 18-60
- Females aged 18-35
- Males defined as Moderate OTA or Isolated Teratozoospermia with less than 4% morphologically normal spermatozoa
- Patients with 0.5- 7% normal sperm according to MSOME analysis
- Females with normal FSH and AMH values
- Females who have retrieved at least 6 oocytes in previous cycles
- Couples who have had at least 2 failed IVF-ICSI cycles
Exclusion
- Couples who have been exposed to heavy smoking, drugs and chronic diseases
- Males who have undergone testicular surgery (TESE) or defined as severe OTA
- Females with egg factor infertility
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03240276
Start Date
September 1 2017
End Date
September 1 2020
Last Update
August 7 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hillel Yaffe Medical Center
Hadera, Israel, 38100